Xwell stock skyrocketed today on a $31.3 million private placement agreement. Here’s why it’s an opportunity to pull out of ...

Avalon GloboCare stock skyrocketed today as its subsidiary secured a spot in AMD's AI Developer Program. Here’s why ALBT ...

Canopy Growth is a penny stock for a reason, so only the most aggressive investors should even be looking at it.

Penny stocks, especially in the early-stage biotech sector, often tend to be volatile and highly risky, but they also offer the potential for massive rewards. One such company is BioXcel Therapeutics ...

Multibagger penny stock: Kabra Drugs shares have proven to be a wealth-creating stock for long-term investors by delivering ...

No, this isn't a pitch to buy penny stocks.

Companies trading under $20 per share often draw institutional and retail investor attention. People like cheap stocks. If ...